(2S,3S,4aR,8aR)-2,3,4a,8a-Tetrahydro-7-iodo-2,3-diMethoxy-2,3-diMethyl-1,4-benzodioxin-6(5H)-one
|
- $1320 - $2200
- Product name: (2S,3S,4aR,8aR)-2,3,4a,8a-Tetrahydro-7-iodo-2,3-diMethoxy-2,3-diMethyl-1,4-benzodioxin-6(5H)-one
- CAS: 334700-48-0
- MF: C12H17IO5
- MW: 368.16
- EINECS:
- MDL Number:
- Synonyms:(2S,3S,4aR,8aR)-2,3,4a,8a-Tetrahydro-7-iodo-2,3-diMethoxy-2,3-diMethyl-1,4-benzodioxin-6(5H)-one;(2S,3S,4aR,8aR)-6-iodo-2,3-dimethoxy-2,3-dimethyl-8,8a-dihydro-4aH-1,4-benzodioxin-7-one;(2S,3S,4aR,8aR)-2,3,4a,5,6,8a-hexahydro-7-iodo-2,3-dimethoxy-2,3-dimethylbenzo[b][1,4]dioxin-6-one;1,4-Benzodioxin-6(5H)-one, 2,3,4a,8a-tetrahydro-7-iodo-2,3-dimethoxy-2,3-dimethyl-, (2S,3S,4aR,8aR)-
2 prices
Selected condition：
Brand
- Medical Isotopes, Inc.
- TRC
Package
- 100mg
- ManufacturerMedical Isotopes, Inc.
- Product number61989
- Product description(2S,3S,4aR,8aR)-2,3,4a,8a-Tetrahydro-7-iodo-2,3-dimethoxy-2,3-dimethyl-1,4-benzodioxin-6(5H)-one
- Packaging100mg
- Price$2200
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberT293735
- Product description(2S,3S,4aR,8aR)-2,3,4a,8a-Tetrahydro-7-iodo-2,3-dimethoxy-2,3-dimethyl-1,4-benzodioxin-6(5H)-one
- Packaging100mg
- Price$1320
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Medical Isotopes, Inc. | 61989 | (2S,3S,4aR,8aR)-2,3,4a,8a-Tetrahydro-7-iodo-2,3-dimethoxy-2,3-dimethyl-1,4-benzodioxin-6(5H)-one | 100mg | $2200 | 2021-12-16 | Buy |
| TRC | T293735 | (2S,3S,4aR,8aR)-2,3,4a,8a-Tetrahydro-7-iodo-2,3-dimethoxy-2,3-dimethyl-1,4-benzodioxin-6(5H)-one | 100mg | $1320 | 2021-12-16 | Buy |
Properties
Boiling point :398.2±42.0 °C(Predicted)
Density :1.62±0.1 g/cm3(Predicted)
solubility :Chloroform, DCM
form :Solid
color :Off-White
Density :1.62±0.1 g/cm3(Predicted)
solubility :Chloroform, DCM
form :Solid
color :Off-White
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|